A “liquid biopsy” that identifies tumor protein biomarkers found in circulating extracellular vesicles (EV) could help detect early-stage pancreatic, ovarian and bladder cancers, results from a new study show.
The platform, developed by San Diego?based Biological Dynamics, identified 71% of stage I cancers in a combined cohort, including 96% of patients with pancreatic cancer, according to the results, which were published in Nature Communications Medicine (